Literature DB >> 11072109

RNA repair: a novel approach to gene therapy.

T Watanabe1, B A Sullenger.   

Abstract

Treatment of genetic disorders by gene therapy has conventionally been attempted through the transfer of a wild type version of a gene to the cells of a patient harboring defective copies of a disease associated gene. Despite significant advances using this paradigm, several technical hurdles must still be overcome before this 'gene replacement' approach will become useful in the treatment of a variety of genetic maladies. Such limitations have led a number of researchers to begin to investigate alternative strategies to genetic therapy. Repair of mutant genetic instructions represents a fundamentally different approach to genetic therapy that may have significant advantages over gene replacement. Herein, we will discuss recent advances using repair of mutant RNAs as a novel means to correct genetic deficiencies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072109     DOI: 10.1016/s0169-409x(00)00089-2

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  5 in total

1.  Functional repair of a mutant chloride channel using a trans-splicing ribozyme.

Authors:  Christopher S Rogers; Carlos G Vanoye; Bruce A Sullenger; Alfred L George
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Selections for constituting new RNA-protein interactions in catalytic RNP.

Authors:  Shota Atsumi; Yoshiya Ikawa; Hideaki Shiraishi; Tan Inoue
Journal:  Nucleic Acids Res       Date:  2003-01-15       Impact factor: 16.971

3.  The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion.

Authors:  Jay N Lozier; Amalia Dutra; Evgenia Pak; Nan Zhou; Zhili Zheng; Timothy C Nichols; Dwight A Bellinger; Marjorie Read; Richard A Morgan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-19       Impact factor: 11.205

Review 4.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.

Authors:  Scott K Silverman
Journal:  Nucleic Acids Res       Date:  2005-11-11       Impact factor: 16.971

5.  Group I aptazymes as genetic regulatory switches.

Authors:  Kristin M Thompson; Heather A Syrett; Scott M Knudsen; Andrew D Ellington
Journal:  BMC Biotechnol       Date:  2002-12-04       Impact factor: 2.563

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.